PHR Phreesia Inc

$17.03

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

In the upcoming earnings report for Phreesia (PHR), investors will be keenly observing how the company navigates its growth trajectory amidst a challenging market landscape. With a market cap of approximately $1.83 billion, Phreesia stands at a pivotal point where its strategic initiatives to enhance patient intake and engagement solutions could significantly impact its financial performance. The revenue estimate of $116.50 million reflects a cautious optimism, aligning closely with the whisper number, which suggests a neutral stance on earnings per share at $0.00. This alignment indicates that market participants are anticipating steady performance without significant surprises. As Phreesia continues to leverage its technological capabilities to streamline healthcare operations, the focus will be on how these efforts translate into sustained revenue growth and operational efficiency. The forthcoming earnings release will be crucial in assessing whether Phreesia can meet or exceed these tempered expectations and maintain its competitive edge in the healthcare technology sector.

Updated On 1/6/2026

About Phreesia Inc

Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.

Website: https://www.phreesia.com

Sector
TRADE & SERVICES
Industry
SERVICES-BUSINESS SERVICES, NEC
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
January
CIK
1412408
Address
434 FAYETTEVILLE ST., SUITE 1400, RALEIGH, NC, US
Valuation
Market Cap
$1.41B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
5.32
Performance
EPS
$-1.02
Dividend Yield
Profit Margin
-13.90%
ROE
-22.70%
Technicals
50D MA
$26.34
200D MA
$23.97
52W High
$30.53
52W Low
$17.07
Fundamentals
Shares Outstanding
59M
Target Price
$31.77
Beta
0.82

PHR EPS Estimates vs Actual

Estimated
Actual

PHR News & Sentiment

Dec 30, 2025 • MyChesCo BULLISH
Phreesia Cracks Top 10 as Software Recognition Signals Healthcare AI Momentum
Phreesia (NYSE: PHR) has achieved a Top 10 ranking on The Software Report’s Top 50 Software Companies of 2025, marking its fourth consecutive appearance and its highest position yet. This recognition underscores the company's innovation in healthcare technology, particularly with the introduction of Phreesia VoiceAI, which aims to simplify patient and provider experiences. The achievement highlights the growing importance of digital tools and conversational automation in streamlining healthcare operations and improving patient engagement.
Dec 23, 2025 • Barron's BULLISH
Phreesia Stock Has Been Crushed. We’re Standing By Our Pick.
Phreesia's stock has seen a significant downturn, but the author believes this presents a compelling buying opportunity. The article suggests that despite the poor performance, the company's valuation and growth prospects remain strong.
Dec 20, 2025 • MyChesCo BULLISH
Phreesia Swings to Profit as Growth Accelerates and AccessOne Deal Lands
Phreesia, Inc. reported a significant financial turnaround in its fiscal third quarter, achieving profitability with $4.3 million in net income and strong cash generation. The healthcare technology company saw revenue climb 13 percent to $120.3 million, driven by client growth and increased revenue per customer. The company also completed its $160 million acquisition of AccessOne and raised its financial outlook for fiscal years 2026 and 2027, anticipating continued growth and operational efficiency.
Dec 20, 2025 • MSN BULLISH
Phreesia swings to profit as growth accelerates and AccessOne deal lands
Phreesia reported a swing to profitability, with strong revenue growth and an improved outlook. The company also announced the acquisition of AccessOne, enhancing its payment platform with patient financing solutions, and detailed several new client partnerships.
Dec 18, 2025 • Business Wire BULLISH
Phreesia Named to The Software Report’s “Top 50 Software Companies” for the Fourth Consecutive Year
Phreesia, a leader in patient intake, outreach, and activation, has been recognized by The Software Report as one of the "Top 50 Software Companies of 2025" for the fourth consecutive year. This year marks Phreesia's first time ranking among the Top 10, highlighting its product excellence, organizational strength, and significant impact on the software industry, particularly with innovations like Phreesia VoiceAI. The company continues its commitment to improving healthcare experiences for patients and providers.
Dec 18, 2025 • MarketBeat SOMEWHAT-BULLISH
Squarepoint Ops LLC Buys 71,553 Shares of Phreesia, Inc. $PHR
Squarepoint Ops LLC significantly increased its stake in Phreesia, Inc. (NYSE:PHR) during Q2, purchasing 71,553 additional shares to bring its total holdings to 100,922 shares valued at $2.87 million. Other institutional investors also boosted their positions in the healthcare IT company, which saw insider selling over the past three months. Analysts maintain a "Moderate Buy" rating with a consensus price target of $31.00, despite the company trading around $16.28 and reporting negative margins, though it did beat quarterly earnings expectations.
Sentiment Snapshot

Average Sentiment Score:

0.327
50 articles with scored sentiment

Overall Sentiment:

Bullish

PHR Reported Earnings

Sep 04, 2025
Jul 31, 2025 (Pre market)
0.07 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.06
  • Whisper:
  • Surprise %: 116.7%
May 28, 2025
Apr 30, 2025 (Post market)
0.65 Surprise
  • Reported EPS: $0.23
  • Estimate: $-0.42
  • Whisper:
  • Surprise %: 153.8%
Mar 12, 2025
Jan 31, 2025 (Pre market)
0.07 Surprise
  • Reported EPS: $0.18
  • Estimate: $0.11
  • Whisper:
  • Surprise %: 67.1%
Dec 09, 2024
Oct 31, 2024 (Post market)
0.31 Surprise
  • Reported EPS: $0.04
  • Estimate: $-0.27
  • Whisper:
  • Surprise %: 113.6%
Sep 04, 2024
Jul 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $-0.31
  • Estimate: $-0.36
  • Whisper:
  • Surprise %: 13.9%
May 30, 2024
Apr 30, 2024 (Post market)
0.13 Surprise
  • Reported EPS: $-0.35
  • Estimate: $-0.48
  • Whisper:
  • Surprise %: 27.1%
Mar 14, 2024
Jan 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $-0.21
  • Estimate: $-0.26
  • Whisper:
  • Surprise %: 19.2%
Dec 05, 2023
Oct 31, 2023 (Post market)
0.11 Surprise
  • Reported EPS: $-0.25
  • Estimate: $-0.36
  • Whisper:
  • Surprise %: 30.6%
Sep 06, 2023
Jul 31, 2023 (Post market)
0.08 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.42
  • Whisper:
  • Surprise %: 19.1%

Financials